Morbidity and mortality in European children vertically infected by HIV-1

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 14, Issue 5, 1997, Pages 442-450

  Blanche, Stéphane ^a,b   Newell, Marie Louise ^d   Mayaux, Marie Jeanne ^c   Dunn, David T ^d   Teglas, Jean Paul ^c   Rouzioux, Christine ^b   Peckham, Catherine S ^b  

^a INSERM   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c South Paris Medical School   (France)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Centers for Disease Control and Prevention classification; Children; Europe; Natural history; Vertically acquired HIV infection

Indexed keywords

ANTIINFECTIVE AGENT; CD4 ANTIGEN; COTRIMOXAZOLE; IMMUNOGLOBULIN; ZIDOVUDINE;

ARTICLE; BACTERIAL INFECTION; CHILD; DISEASE CLASSIFICATION; DISEASE COURSE; HEALTH CARE PLANNING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROPHYLAXIS; VERTICAL TRANSMISSION;

ADULT; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE PROGRESSION; DISEASE TRANSMISSION, VERTICAL; EUROPE; FEMALE; FOLLOW-UP STUDIES; FRANCE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE TOLERANCE; INCIDENCE; INFANT; INFANT, NEWBORN; LIFE TABLES; MORBIDITY; PREGNANCY; PROSPECTIVE STUDIES;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 3142606341     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199704150-00008     Document Type: Article

References (42)

1. Oleske J, Minnefor A, Cooper R, et al. Immune deficiency in children. JAMA 1983;249:2345-9.
2. Rubinstein A, Siclick M, Gupta A, et al. AIDS with reversed T4/T8 ratios in infants born to promiscuous and drug addicted mothers. JAMA 1983;249:2350-6.
3. Scott G B, Buck B E, Leterman J G, et al. AIDS in infants. N Engl J Med 1984;310:76-81.
4. Blanche S, Le Deist F, Fischer A, et al. Longitudinal analysis of 18 children with perinatal LAV/HTLV III infection. Attempt at prognostic evaluation. J Pediatr 1986;109:965-70.
5. Italian Register for HIV infection in children. Features of children perinatally infected with HIV-1 surviving longer than 5 years. Lancet 1994;343:191-5.
6. Grubman S, Gross E, Lerner-Weiss N, et al. Older children and adolescents living with perinatally acquired human immunodeficiency virus. Pediatrics 1995;95:657-63.
7. European Collaborative Study. Natural history of vertically acquired human immunodeficiency virus-1 infection. Pediatrics 1994;94:815-9.
8. Auger I, Thomas P, Gruttola V, et al. Incubation period for paediatric AIDS. Nature 1988;336:575-7.
9. Downs A, Salamina G, Ancelle-Park R A. Incubation period of vertically acquired AIDS in Europe before widespread use of prophylactic therapies. J AIDS 1995;9:297-304.
10. Barnhart H X, Caldwell M B, Thomas P, et al. Natural history of HIV disease in perinatally infected children: an analysis from the pediatric spectrum of disease project. Pediatrics 1996;97:710-6.
11. Galli L, De Martino M, Tovo P A, et al. Onset of clinical signs in children with HIV-1 perinatal infection. AIDS 1995; 9:455-61.
12. European Collaborative Study. Children born to women with HIV-1 infection: natural history and risk of transmission. Lancet 1991;337:253-60.
13. Blanche S, Mayaux M J, Rouzioux C, et al. Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery. N Engl J Med 1994; 330:308-12.
14. Lindgren S, Anzen B, Bohlin A B, et al. HIV and childbearing: clinical outcome and aspects of mother to infant transmission. AIDS 1991;5:1111-6.
15. Hutto C, Parks W P, Lai S, et al. A hospital-based prospective study of perinatal infection with human immunodeficiency virus type 1. J Pediatr 1991;118:347-53.
16. Centers for Disease Control and Prevention 1994 revised classification system for HIV infected children (<13 years old). MMWR 1994;43(RR-12):1-10.
17. Mayaux M J, Burgard M, Teglas J P, et al. Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 infection: JAMA 1996;275:606-10.
18. Connor E, Sperling R, Gelber R, et al. Decreased maternalinfant transmission of human immunodeficiency virus 1 associated with zidovudine treatment. N Engl J Med 1994;331: 1173-80.
19. Rutherford G W, Lifwon A R, Hessol N A, et al. Course of HIV-1 infection in a cohort of homosexual and bisexual men: an 11 year follow-up study. Br Med J 1990;301:1183-8.
20. Selwyn P A, Alcabes P, Hartel D, et al. Clinical manifestations and predictors of disease progression in drug users with HIV infection. N Engl J Med 1992;327:1697-703.
21. Chaisson R E, Keruly J C, Moore R D, Race sex drug use and progression of human immunodeficiency virus disease. N Engl J Med 1995;333:751-6.
22. Bacchetti P. Estimating the incubation period of AIDS by comparing population infection and diagnosis patterns. J Am Stat Assoc 1990;85:1002-8.
23. Phair J, Jacobson L, Detels R, et al. Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type 1: the Multicenter AIDS Cohort Study. J AIDS 1992;5:490-6.
24. Mellors J W, Kingsley A, Rinaldo C R, et al. Quantification of HIV-RNA in plasma predicts outcome after seroreversion. Ann Intern Med 1995;122:573-9.
25. Kaplan J E, Masur H, Holmes K K, et al. USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons infected with HIV: an overview, Clin Infect Dis 1995;21 (suppl 1):12-31.
26. Centers for Disease Control and Prevention 1995 revised guidelines for prophylaxis against Pneumocyslis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. MMWR 1995;44(RR-4):1-11.
27. Just JJ, Abrams E, Louie LG. Influence of host genotype on progression to acquired immunodeficiency syndrome among children infected with human immunodeficiency virus type 1. J Pediatr 1995;127:544-9.
28. Rossi A, Giaquinto C, Ometto L, et al. Replication and tropism of HIV-1 as predictors of disease outcome in infants with vertically acquired infection. J Pediatr 1993;123:929-36.
29. Rouzioux C, Costagliola D, Burgard M, et al. Estimated timing of mother to child human immunodeficiency virus type 1 (HIV-1) transmission by use of a markov model. Am J Epidemiol 1995;142:1330-7.
30. Krivine A, Firtion G, Cao L, et al. HIV replication during first weeks of life. Lancet 1992;339:1187-9.
31. Dickover RE, Dillon M, Guette SG, et al. Rapid increase in load of human immunodeficiency virus correlate with early disease and loss of CD4 cells in vertically infected infants. J Infect Dis 1994;170:1279-84.
32. Ahmenti A, Luzuriaga K, Stechenberg B, Sullivan JL. Quantification of HIV in infected children born to seropositive mothers. AIDS 1993;7:1271-2.
33. Rogers MF, Ou CY, Rayfield, et al. Use of polymerase chain reaction for early detection of the proviral sequence of human immunodeficiency virus in infants born to seropositive mothers. N Engl J Med 1989;320:1649-54.
34. Burgard M, Mayaux MJ, Blanche S, et al. The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates. N Engl J Med 1992: 327:1192-7.
35. De Martino, Tovo PA, Galli C, et al. Prognostic significance of immunologic changes in 675 infants perinataly exposed to human immunodeficiency virus. J Pediatr 1991;119:702-9.
36. Duliege AM, Messiah A, Blanche S, et al. Natural history of HIV-1 infection in children: prognostic value of laboratory test on the bimodal progression of the disease. Pediatr Infect Dis J 1992;11:630-6.
37. Buseyne F, Blanche S, Schmitt D, et al. Detection of HIV-specific cell mediated cytotoxicity in the peripheral blood from infected children. J Immunol 1993;150:3569-81.
38. Pollack H, Xia-Zhan M, Ilmet-Moore T, et al. Ontogeny of antihuman immunodeficiency virus (HIV) antibody production in HIV-1 infected infants. Proc Natl Acad Scii U S A 1993;90:2340-3.
39. Easterbrook PJ. Non progression in HIV infection. AIDS 1994;8:1179-82.
40. Concorde Coordinating Committee. Concorde MRC-ANRS randomised doubled blind controlled trial of immediate and deferred Zidovudine in symptom free HIV infection. Lancet 1994;343:871-81.
41. Volberding PA, Lagakos SW, Grimes JM, et al. A comparison of immediate versus deferred zidovudine therapy for asymptomatic HIV infected adults with CD4 cell count of 500 or more per cubic millimeter. N Engl J Med 1995;333:408-13.
42. Spector SA, Gelber RD, McGrath N, et al. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced HIV infection. N Engl J Med 1994;331:1181-7.